Author

Rachel L. Dannenberg

Pennsylvania State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

Mark HedgliniD· 3 shared Angela M. HinchieiD· 1 shared Edwin AntonyiD· 1 shared Grace Young· 1 shared Helen Washington· 1 shared Jessica L. Norris· 1 shared Jonathan K. AlderiD· 1 shared Joseph A. Cardina· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiophysics

Mark HedglinORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PCNA encircling primer/template junctions is eliminated by exchange of RPA for Rad51: Implications for the interplay between human DNA damage tolerance pathways

Jessica L. Norris, Lindsey O. Rogers, Grace Young, Kara G Pytko, Rachel L. Dannenberg, Samuel Perreault, Vikas Kaushik, Edwin Antony, Mark Hedglin

This study investigates the interplay between DNA damage tolerance pathways by comparing PCNA occupancy and RPA/Rad51 exchange at stalled replication sites.

Nucleic Acids Research · Dec 17, 2025Peer-reviewedBiophysics

A human high-fidelity DNA polymerase holoenzyme has a wide range of lesion bypass activities

Rachel L. Dannenberg, Joseph A. Cardina, Helen Washington, Shijun Gao, Marc M. Greenberg, Mark Hedglin

This study shows human pol δ holoenzymes can bypass various lesions with insertion and extension efficiencies ranging from 0 to 100%.

Nucleic Acids Research · Jul 8, 2025Peer-reviewedBiochemistry

Chemotherapeutic 6-thio-2-deoxyguanosine selectively targets and inhibits telomerase by inducing a non-productive telomere-bound telomerase complex

Samantha L. Sanford, Mareike Badstübner, Michael H. Gerber, William P. Mannherz, Noah M. Lampl, Rachel L. Dannenberg, Angela M. Hinchie, Matthew A Schaich, Sua Myong, Mark Hedglin, Suneet Agarwal, Jonathan K. Alder, Michael D. Stone, Patricia Lynn Opresko

This study shows 6-thio-dG inhibits telomerase by forming a non-productive complex, affecting telomere maintenance in cancer cells.

bioRxiv · Feb 5, 2025 · PreprintCancer Biology